We are live on
!
Find out more
Sana Biotechnology
SANA
SANA
80 hedge funds and large institutions have $1.93B invested in Sana Biotechnology in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 12 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
131,700% more call options, than puts
Call options by funds: $1.32M | Put options by funds: $1K
175% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 12
12% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 17
3.04% more ownership
Funds ownership: 49.34% → 52.38% (+3%)
3% more funds holding
Funds holding: 78 → 80 (+2)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
38% less capital invested
Capital invested by funds: $3.1B → $1.93B (-$1.16B)
Holders
80
Holders Change
+2
Holders Change %
+2.56%
% of All Funds
1.39%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
19
Increased
33
Reduced
12
Closed
17
Calls
$1.32M
Puts
$1K
Net Calls
+$1.32M
Net Calls Change
+$1.32M
Top Buyers
Top Sellers
| 1 |
SCM
Suvretta Capital Management
New York
|
-$12.9M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$12.2M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$8.15M |
| 4 |
EC
EMJ Capital
Toronto,
Ontario, Canada
|
-$6.69M |
| 5 |
JP Morgan Chase
New York
|
-$6.11M |
